Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vericel Corproation (VCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
What Makes Vericel (VCEL) a New Buy Stock

Vericel (VCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VCEL : 19.25 (+4.00%)
Vericel to Present at Multiple Upcoming Investor Conferences

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced presentations at multiple upcoming investor conferences.

VCEL : 19.25 (+4.00%)
Vericel (VCEL) Tops on Q4 Earnings & Sales, Stock Up

Vericel (VCEL) beat estimates for earnings as well as revenues in fourth-quarter 2018. Shares up in pre-market trading.

VCEL : 19.25 (+4.00%)
Vericel Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Full-Year 2019 Financial Guidance

Record Quarterly Product Revenues of $31.3 Million Represent a 41% Increase Over Fourth Quarter 2017

VCEL : 19.25 (+4.00%)
What's in Store for Vericel (VCEL) This Earnings Season?

On Vericel's (VCEL) fourth-quarter conference call, investor focus will be on the sales figures of the company's two approved medicines -- MACI and Epicel.

CARA : 19.63 (+1.34%)
BDSI : 5.22 (-0.95%)
VCEL : 19.25 (+4.00%)
ADRO : 3.89 (-0.51%)
Vericel to Participate in Multiple Upcoming Investor Conferences

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced participation in multiple upcoming investor conferences.

VCEL : 19.25 (+4.00%)
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter...

VCEL : 19.25 (+4.00%)
Vericel to Present at the 21st Annual Needham Growth Conference

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest...

VCEL : 19.25 (+4.00%)
Bull or Bear: Your Investment Strategy for 2019

Whether you're a bull or a bear, it may be a good idea to go defensive about now.

SCS : 15.46 (+2.32%)
VCTR : 15.38 (+3.71%)
INTT : 7.09 (+0.57%)
MMI : 39.17 (+0.90%)
III : 3.70 (+0.27%)
TIVO : 9.42 (+0.32%)
BEAT : 68.89 (+1.50%)
BMA : 51.78 (-1.30%)
DIOD : 37.77 (+1.86%)
PGR : 72.84 (+1.15%)
CPSI : 30.07 (+0.40%)
VCEL : 19.25 (+4.00%)
BHC : 25.41 (+0.16%)
VNDA : 18.42 (+2.91%)
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research

Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the publication of outcomes data for 954 burn patients treated...

VCEL : 19.25 (+4.00%)
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise

Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise

AYX : 84.86 (+4.77%)
MITK : 11.80 (+1.03%)
MTLS : 17.11 (+1.60%)
VCEL : 19.25 (+4.00%)
4 Stocks With Recent Price Strength to Maximize Your Gains

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

AYX : 84.86 (+4.77%)
MITK : 11.80 (+1.03%)
MTLS : 17.11 (+1.60%)
VCEL : 19.25 (+4.00%)
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year?

Is (VCEL) Outperforming Other Medical Stocks This Year?

VCEL : 19.25 (+4.00%)
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath

Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.

AMED : 126.14 (+1.91%)
CROX : 25.63 (-0.04%)
ACMR : 16.31 (+2.39%)
ATTU : 23.33 (+0.13%)
VCEL : 19.25 (+4.00%)
4 Healthcare Stocks That Popped More Than 100% in 2018

Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.

AMED : 126.14 (+1.91%)
STAA : 38.93 (+2.56%)
VCEL : 19.25 (+4.00%)
DXCM : 142.16 (-2.74%)
Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk

Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk

TGNA : 14.15 (+1.00%)
MINI : 35.05 (+0.31%)
SPLK : 130.80 (+0.62%)
VCEL : 19.25 (+4.00%)
Four Biotech Stocks That Popped More Than 50% in 2018

Four Biotech Stocks That Popped More Than 50% in 2018

GHDX : 74.67 (+1.70%)
VCEL : 19.25 (+4.00%)
NCNA : 17.06 (+6.62%)
VNDA : 18.42 (+2.91%)
4 Best Stocks That Flaunt Superb Earnings Acceleration

Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.

TGNA : 14.15 (+1.00%)
MINI : 35.05 (+0.31%)
SPLK : 130.80 (+0.62%)
VCEL : 19.25 (+4.00%)
Vericel (VCEL) Flat As Market Sinks: What You Should Know

Vericel (VCEL) closed the most recent trading day at $17.10, making no change from the previous trading session.

VCEL : 19.25 (+4.00%)
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year?

Is (VCEL) Outperforming Other Medical Stocks This Year?

VCEL : 19.25 (+4.00%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ -0.02
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar